Changmao Biochemical Engineering Co., Ltd (HKG:8208)
Price:
0.93
Change:
+0.01 +1.09%
3/28/2013 3:50am ET |
|
| Daily Chart |
|
 |
| Price: |
0.93
|
| Change: |
+0.01 +1.09%
|
| Open: |
0.96 |
| High: |
0.96 |
| Low: |
0.92 |
| Vol: |
464,000
|
| Market Cap: |
171.1M |
| P/E: |
7.94 |
| 52wk Range: |
0.50 - 1.25 |
| EPS: |
0.1159 |
|
|
| Financial brief |
| For the fiscal year ended 31 December 2010, Changmao Biochemical Engineering Co., Lt's revenues increased 34% to RMB515.6M. Net income increased 75% to RMB75.8M. Revenues reflect an increase in income from China, higher income from Europe and an increase in income from Asia pacific. Net income also reflects a higher gross profit margin, an increase in operating profit, a decrease in finance cost, net, and an increase in share of profit of an associates. |
|
| Related news |
More... |
• Changmao Biochem (HKG:8208) 1H net profit RMB24.5M, down 10%; no div 8/8/2012
Results of Changmao Biochemical Engineering Company Limited (HKG:8208) for the first 6 months ended 30 June 2012:
Net profit: RMB24.491M, down 10.39% YoYEPS: RMB0.046Interim dividend: nil... |
• Changmao Biochem (HKG:8208) Q1 net profit RMB5.6M, down 58%; no div 5/8/2012
Results of Changmao Biochemical Engineering (HKG:8208) for the first 3 months ended 31 March 2012:
Net profit: RMB5.603M, down 58.1% YoYEPS: RMB0.011Dividend: nil... |
• Changmao Biochem (HKG:8208) expects lower NP for Q1 4/24/2012
Changmao Biochemical Engineering Company (HKG:8208) announces that although there is an estimated increase in the group's turnover for the three months ended 31 March 2012, the group is likely to record a decline in the consolidated net profits for the three months ended 31 March 2012 as compared to the consolidated net profits for the three months ended 31 ... |
• Changmao Biochem (HKG:8208) 2011 net profit RMB41M; div RMB0.024 3/19/2012
Results of Changmao Biochemical Engineering Company (HKG:8208) for the year ended 31 December 2011:
Net profit: RMB41.105M, down 45.75% YoYEPS: RMB0.078Final dividend: RMB0.024... |
• Changmao Biochem (HKG:8208) expects lower net profit for 2011 2/6/2012
Changmao Biochemical Engineering (HKG:8208) says that although there is an estimated increase in its group's turnover for the year ended 31 December 2011, the group is likely to record a decline in the consolidated net profits for that year, as compared with the consolidated net profits for the year of 2010.
The board believes that the group's financial perf... |
• Changmao Biochem (HKG:8208) 9-month net profit RMB42M; no div 11/9/2011
Results of Changmao Biochemical Engineering (HKG:8208) for the 9 months ended 30 September 2011:
Net profit: RMB42.113M, down 2.33% YoYEPS: RMB0.08Dividend: Nil
Results for the 3 months ended 30 September 2011:
Net profit: RMB14.781M, down 8.06% YoYEPS: RMB0.028 ... |
• Changmao Biochem (HKG:8208) 1H net profit RMB27.33M, up 1%; no div 8/9/2011
Results of Changmao Biochemical Engineering Company Limited (HKG:8208) for the 6 months ended 30 June 2011:
Net profit: RMB27.332M, up 1.07% YoYEPS: RMB0.052Interim dividend: Nil... |
• Changmao Biochem (HKG:8208) Q1 net profit RMB13.4M, up 28%; no div 5/4/2011
For the three months ended 31 March 2011, Changmao Biochemical Engineering (HKG:8208) had a net profit of RMB13.371 million, up 27.54% on year. Earnings per share were RMB0.025. No quarterly dividend is declared. ... |
• Changmao Biochem (HKG:8208) 2010 net profit RMB76M; div RMB0.043 3/9/2011
Changmao Biochemical Engineering (HKG:8208) said profit attributable to equity holders of the company amounted to RMB75.773 million for 2010, up 75% over the previous year.
The EPS were RMB0.122. A final dividend of RMB0.043 was declared.... |
• Changmao (HKG:8208) to convert domestic shr to foreign shares 1/21/2011
Changmao Biochemical Engineering (HKG:8208) announced that it will convene an extraordinary general meeting on 10 March 2011 to consider and approve the proposal for conversion of 62.5 million domestic shares into 62.5 million foreign shares.... |
|
|
| Summary |
|
Changmao Biochemical Engineering Company Limited (Changmao) is engaged in the production and sale of organic acids in the People’s Republic of China. Changmao produces organic acids for sale to food additive, chemical and pharmaceutical industries. The core products of the Company and its subsidiaries are organic acids and their derivatives with four carbons in their structures, including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid and aspartame. These products are mainly used as food additives or medical intermediaries. Most of the Company’s products are exported to Western Europe, Australia, the United States and Japan. The Company’s subsidiaries include Shanghai Changmao Biochemical Engineering Company Limited and Shanghai Medical Life Science Research Centre Limited. As of December 31, 2009, the Company held a 38.78% interest in Changzhou Lanling Pharmaceutical Production Co., Ltd. |
| Contact |
|
Room 54, 5F New Henry House 10 Ice House Street Central |
|
Hong Kong |
|
+85225252821 (Phone) |
|
+85225252242 (Fax) |
| Website |
|
www.cmbec.com/
|
|
| Information is provided 'as is' and solely for informational
purposes, not for trading purposes or advice, and may be delayed. |
|
|
|
Chinese Stock List
